These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35713165)

  • 21. [Enzymatic evidence of the depth dependence of stiffening on riboflavin/UVA treated corneas].
    Schilde T; Kohlhaas M; Spoerl E; Pillunat LE
    Ophthalmologe; 2008 Feb; 105(2):165-9. PubMed ID: 17955247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An in vitro investigation into the impact of corneal rinsing on riboflavin/UVA corneal cross-linking.
    Morgan SR; O'Brart DPS; Huang J; Meek KM; Hayes S
    Eye Vis (Lond); 2024 Feb; 11(1):8. PubMed ID: 38414033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corneal biomechanical properties following corneal cross-linking: Does age have an effect?
    Alenezi B; Kazaili A; Akhtar R; Radhakrishnan H
    Exp Eye Res; 2022 Jan; 214():108839. PubMed ID: 34785203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficiency of cross-linking methods in eradication of bacteria is influenced by the riboflavin concentration and the irradiation time of ultraviolet light.
    Bäckman A; Makdoumi K; Mortensen J; Crafoord S
    Acta Ophthalmol; 2014 Nov; 92(7):656-61. PubMed ID: 25493311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of UVA-riboflavin cross-linking of the cornea.
    Spoerl E; Mrochen M; Sliney D; Trokel S; Seiler T
    Cornea; 2007 May; 26(4):385-9. PubMed ID: 17457183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro.
    Wollensak G; Spoerl E; Reber F; Seiler T
    Eye (Lond); 2004 Jul; 18(7):718-22. PubMed ID: 14739922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Riboflavin-UVA treatment in the management of edema and nonhealing ulcers of the cornea.
    Ehlers N; Hjortdal J; Nielsen K; Søndergaard A
    J Refract Surg; 2009 Sep; 25(9):S803-6. PubMed ID: 19772255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro quantification of the stiffening effect of corneal cross-linking in the human cornea using radial shearing speckle pattern interferometry.
    Knox Cartwright NE; Tyrer JR; Marshall J
    J Refract Surg; 2012 Jul; 28(7):503-8. PubMed ID: 22833877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The comparative safety of genipin versus UVA-riboflavin crosslinking of rabbit corneas.
    Song W; Tang Y; Qiao J; Li H; Rong B; Yang S; Wu Y; Yan X
    Mol Vis; 2017; 23():504-513. PubMed ID: 28761323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic efficacy of ultraviolet combined with riboflavin for the rabbit bacterial keratitis].
    Su GY; Zheng PP; Su YD; Cao K; Gao C; Zhang Y; Li B; Liang QF
    Zhonghua Yan Ke Za Zhi; 2018 Dec; 54(12):902-910. PubMed ID: 30526789
    [No Abstract]   [Full Text] [Related]  

  • 31. Corneal Cross-Linking: Evaluating the Potential for a Lower Power, Shorter Duration Treatment.
    Caruso C; Barbaro G; Epstein RL; Tronino D; Ostacolo C; Sacchi A; Pacente L; Del Prete A; Sala M; Troisi S
    Cornea; 2016 May; 35(5):659-62. PubMed ID: 26989958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bactericidal Efficacy of High Irradiance Ultraviolet A Photoactivation of Riboflavin Versus Standard Corneal Cross-Linking Protocol In Vitro.
    Tarff A; Drew-Bear LE; Yee R; Cano M; Zhang Y; Behrens A
    Cornea; 2022 Sep; 41(9):1166-1170. PubMed ID: 35849757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrastromal application of riboflavin for corneal crosslinking.
    Seiler TG; Fischinger I; Senfft T; Schmidinger G; Seiler T
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4261-5. PubMed ID: 24917136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic effects of ultraviolet A/riboflavin and glucose on corneal collagen cross-linking.
    Xia Y; Tao C; Zhou C; Ren Q
    J Refract Surg; 2011 Mar; 27(3):216-22. PubMed ID: 21188957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology.
    Price MO; Tenkman LR; Schrier A; Fairchild KM; Trokel SL; Price FW
    J Refract Surg; 2012 Oct; 28(10):706-13. PubMed ID: 23062001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between three different high fluence UVA levels in corneal collagen cross-linking for treatment of experimentally induced fungal keratitis in rabbits.
    Awad R; Hafezi F; Ghaith AA; Baddour MM; Awad K; Abdalla M; Sheta E; Sultan GM; Elmassry A
    Eur J Ophthalmol; 2022 Jul; 32(4):1907-1914. PubMed ID: 35384782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated application of riboflavin during corneal cross-linking does not improve the biomechanical stiffening effect ex vivo.
    Abdshahzadeh H; Abrishamchi R; Aydemir ME; Hafezi N; Hillen M; Torres-Netto EA; Lu NJ; Hafezi F
    Exp Eye Res; 2022 Nov; 224():109267. PubMed ID: 36167218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corneal wound healing after ultraviolet-A/riboflavin collagen cross-linking: a rabbit study.
    Salomão MQ; Chaurasia SS; Sinha-Roy A; Ambrósio R; Esposito A; Sepulveda R; Agrawal V; Wilson SE
    J Refract Surg; 2011 Jun; 27(6):401-7. PubMed ID: 21162471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of fluorescein on the antimicrobial efficacy of photoactivated riboflavin in corneal collagen cross-linking.
    Richoz O; Gatzioufas Z; Francois P; Schrenzel J; Hafezi F
    J Refract Surg; 2013 Dec; 29(12):842-5. PubMed ID: 24404606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomechanical evidence of the distribution of cross-links in corneas treated with riboflavin and ultraviolet A light.
    Kohlhaas M; Spoerl E; Schilde T; Unger G; Wittig C; Pillunat LE
    J Cataract Refract Surg; 2006 Feb; 32(2):279-83. PubMed ID: 16565005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.